Best Drug Discovery Software - Page 5
Drug discovery software is used to develop new pharmaceutical drugs and test whether a newly created drug will be effective in treating a particular disease. Drug discovery software automates and leverages innovative technology that significantly cuts down on the arduous process of drug development, testing, and going to market.
Most drug discovery solutions offer screening, predictive analytics, modeling, simulation, and computational capabilities. Those functionalities help with tasks such as image analysis and clinical trial results submission, as well as ensuring accurate reproducibility. Researchers and scientists use drug discovery software to gain market intelligence, take advantage of advancements in drug design and synthesis, tackle evolving and adapting diseases, and maintain and manage the integrity of data as drugs transition from the discovery phase to the clinical trial phase.
To qualify for inclusion in the Drug Discovery category, a product must:
Best Drug Discovery Software At A Glance
G2 takes pride in showing unbiased reviews on user satisfaction in our ratings and reports. We do not allow paid placements in any of our ratings, rankings, or reports. Learn about our scoring methodologies.
A weekly snapshot of rising stars, new launches, and what everyone's buzzing about.
- Overview
- Seller Details
SpliceCore is a dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data.
1,129 Twitter followers
- Overview
- Seller Details
With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies within a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from
548 Twitter followers
- Overview
- Seller Details
Elucidate complex structures from experimental data with the help of expert algorithms
1,027 Twitter followers
- Overview
- Seller Details
SYNTHIA Retrosynthesis Software is a cloud-based, software-as-a-service (SaaS) platform that helps chemists rapidly design robust synthetic routes using expert-coded rules curated by chemists and engi
12,600 Twitter followers
- Overview
- Seller Details
Eidogen-Sertanty's Target Informatics Platform (TIP) is the world's first structural informatics system and knowledgebase that enables researchers with the ability to interrogate the druggable genome
19 Twitter followers
- Overview
- Seller Details
Torx is a visual, chemistry aware, web-based platform that inspires discovery chemistry teams to work together and deliver faster. Dedicated stand-alone modules for Design, Make, Test and Analyze wor
- Overview
- Seller Details
Calculate drug toxicity and safety endpoints to reduce attrition rates of molecular entities that are unlikely to succeed to nomination as a drug candidate, direct new compound synthesis, and focus an
1,027 Twitter followers
- Overview
- Seller Details
Pioneering an approach that combines simulation with machine learning, we map and model how thousands of signaling proteins interact characterizing cellular level cancer behavior and response or resis
- Overview
- Seller Details
twoXAR is an artificial intelligence-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinic
10 Twitter followers
- Overview
- Seller Details
2D to 3D small molecule conversion. Provides low energy conformers of drug-like molecules. Detects and enforces stereochemistry.
- Overview
- Seller Details
A comprehensive free energy software package for computer-aided drug discovery and molecular design.
- Overview
- Seller Details
Xavo is a cloud-native Sample Management Software-as-a-Service platform designed to streamline laboratory operations by integrating systems, devices, and processes into a cohesive environment. It enab
- Overview
- Seller Details
Xavo has reimagined how to address the strategic problem in the Biopharma R&D Sample Management realm which is to optimally fulfill changing demand for assays and materials based on available fini
